Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-11 | Entrada Therapeutics, Inc. | Sethuraman Natarajan
(President, Research & Develop.) |
S | Common Stock | D | 4109 | $20.01 - $20.04 | $82,299 |
| 2024-11-11 | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES
(Chief Financial Officer) |
S | Common Stock | D | 8637 | $19.98 - $19.98 | $172,562 |
| 2024-11-11 | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES
(Chief Financial Officer) |
M | Common Stock | A | 6000 | $2.10 - $2.10 | $12,600 |
| 2024-11-04 | Entrada Therapeutics, Inc. | Sethuraman Natarajan
(President, Research & Develop.) |
S | Common Stock | D | 18219 | $18.02 - $19.32 | $339,279 |
| 2024-10-16 | Entrada Therapeutics, Inc. | Sethuraman Natarajan
(President, Research & Develop.) |
S | Common Stock | D | 600 | $18.00 - $18.00 | $10,800 |
| 2024-09-26 | Entrada Therapeutics, Inc. | Dowden Nathan J
(President & COO) |
S | Common Stock | D | 847 | $16.00 - $16.00 | $13,552 |
| 2024-09-09 | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES
(Chief Financial Officer) |
S | Common Stock | D | 3195 | $14.97 - $14.97 | $47,832 |
| 2024-09-06 | Entrada Therapeutics, Inc. | Dowden Nathan J
(President & COO) |
S | Common Stock | D | 2303 | $15.07 - $15.19 | $34,752 |
| 2024-09-06 | Entrada Therapeutics, Inc. | Sethuraman Natarajan
(Chief Scientific Officer) |
S | Common Stock | D | 3242 | $15.09 - $15.24 | $49,003 |
| 2024-07-12 | Entrada Therapeutics, Inc. | Sethuraman Natarajan
(Chief Scientific Officer) |
S | Common Stock | D | 1238 | $18.00 - $18.00 | $22,284 |
| 2024-07-12 | Entrada Therapeutics, Inc. | Doshi Dipal
(CEO) |
S | Common Stock | D | 1900 | $17.81 - $18.00 | $33,897 |
| 2024-07-08 | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES
(Chief Financial Officer) |
S | Common Stock | D | 1758 | $14.95 - $14.95 | $26,282 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |